New Innovations in Disease Diagnosis: A Review

Abstract

A disease or medical and an abnormal condition happened to the body or mind. It causes pain, dull feeling and lastly death. It includes: parts of the body being hurt, not having the usual abilities, medical problems or organ malfunction, microbial infections, health issues, having pain or bad symptoms, unusual body shapes. The study of disease is called pathology. Disease can be described as a medical condition associated with particular symptoms and signs. It can be caused by external factors like pathogens, or caused by internal malfunctions mainly the immune system such as an immunodeficiency, or a hypersensitivity such as allergies and autoimmunity. Diseases are broadly classified to any abnormal condition that causes pain, dysfunction, distress, or death to the person affected with similar problems. It includes injuries, disabilities, disorders, syndromes, infections, isolated symptoms, deviant behaviours, and atypical variations of structure and its function and for others these may be considered as distinguishable categories. Diseases can affect people not only physically and mentally, as living with a disease will alter the affected person's thinking ability. Death caused by disease are often natural. Diseases are categorised into four main types: infectious diseases, deficiency diseases, genetic diseases and physiological diseases. Diseases can be classified as contagious and non-contagious. The fatal diseases in humans are HIV, Coronary Artery Disease, Chronic Obstructive Pulmonary Disease and cancer.

Introduction to Death Causing Diseases

The human suffering and death caused by many bacteria called as microorganisms which establish the presence of infectious diseases. In spite of the outraging successes in control by improved sanitation, immunization and antimicrobial therapy, the infectious diseases continue to be a common and significant problem in disease diagnosis [1-20]. The most common disease is common cold and HIV leading to AIDS. The chronic neurological diseases that were thought degenerative have confirmed to be infectious. The future will continue to reveal the infectious diseases as a major medical issues. Clinicians use some terms that are not easy to define a particular disease. Infection can be defined as as a microbial growth with a host response including essential features. Human body surfaces that communicate with the external environment (e.g., skin, small intestine and trachea) support a normal flora and they usually do not cause disease. The microbial flora can invade and produce an infection under the right situations.

There are other medical terms which are commonly used in describing the infectious diseases. Pathology refers to the abnormality shown by a bacterial infection and pathogenesis are the events produced by the bacteria. A pathogenic microorganism is a microbe that leads to pathological symptoms and death lastly. The presence of pathological symptoms and an infectious disease is a disease caused by a microorganism [21-30]. Virulence refers to power of a microorganism to cause a disease in a host. For eg: a microorganism may be non-infectious for a normal host and highly virulent for an immunosuppressed host. Immunity refers to the degree of resistance of the host for a particular microbe. The occurrence of an infectious disease in humans is a motivating process that represents a host-parasite interaction. The parasite multiplies in number and host pursues to control. The physicians work is to recognize that process and to interrupt it which accounts for the patient's illness.

The infectious diseases are usually characterized by the involved organs or organ system. This is useful and acts as a device in infected patients. For eg. patients do not complain about pneumococcal pneumonia but complain about fever, cough and chest pain. The physician judges based on the occurrence of the disease, if it is to chest calls it as respiratory infection and then ensure to develop data proving pneumonia [30-40]. Based on the location we differentiate infections as follows: respiratory, gastrointestinal, genitourinary, nervous system, skin and soft tissue, bone and joint, cardiovascular and generalized infections. The diagnosis, prevention, pathogenesis and treatment of the infectious diseases is a stimulating process.

The 10 fatal diseases currently running in the world are:

1. Heart disease

2. Brain stroke

3. Chronic Obstructive Pulmonary Disease

4. Human Immunodefiency virus/ Acquired Immunodeficiency Syndrome

5. Prenatal deaths of newborns

6. Respiratory diseases

7. Organ Cancers (Trachea, Bronchus and Lung)

8. Water borne diseases (Diarrhea)

9. Diabetes

10. Airborne disease (Tuberculosis)

Some Diseases and Their Diagnosis

Heart Disease

Heart disease is also called as coronary artery disease (CAD) or ischemic heart disease (IHD) that occurs due to narrowed blood vessels. The diagnosis of CAD can be done in many ways: Echocardiography, Electrocardiogram (EKG), Stress testing, Chest X Ray, Coronary Angiography and Cardiac Catheterization. It is a simple, painless test which detects and records the heart's electrical activity. This detect and show the heart beat whether it is in rhythm i.e. normal or abnormal. An EKG also records the strength and timing of electrical signals as they pass through the heart. It reveals heart damage due to CHD and reminds of previous and current heart symptoms. About 599,000 people die of heart disease every year in the United States. The major risk factors are high blood pressure, high cholesterol and smoking. Regular exercise, good nutrition and diet can help to decrease this risk.

Brain Stroke

Brain stroke occurs when a brain artery is blocked. Oxygen-deprived brain cells die within 4 minutes. Risk factors for stroke are similar for CAD and good health can lower this risk. The main symptoms of this are: speaking and understanding trouble, paralysis or numbness of the external organs, sight trouble, Headache, walking trouble. It is also called as haemorrhagic brain stroke [41-60]. Stroke is a medical emergency. Rapid treatment will save your life and enhance your chances of recovery.

Chronic Obstructive Pulmonary Disease

COPD is a chronic and progressive lung disease that makes problem in breathing. Chronic bronchitis and emphysema are COPD types. According to WHO, approximately 3.1 million deaths occurred due to COPD in USA. That represents about 5.6 % of death rate is found since 2000. In 2004, about 64 million people around the world were living with COPD [61-80]. The main cause agent of COPD is smoking. The other factor is by both indoor and outdoor air pollution. COPD affects men and women at the same rate. There is no cure for COPD but its movement can be decreased with medication.

Human Immunodefiency Virus/ Acquired Immunodeficiency Syndrome (Hiv/Aids)

HIV is a short form of human immunodeficiency virus. A virus that attacks and disturbs the immune system from top to bottom. HIV is the main causative agent of AIDS. AIDS is a chronic and life-threatening condition leading to death. According to the Foundation for AIDS Research, almost 39 million people have died due to HIV/AIDS. About 1.5 million people lost their lives suffering from AIDS. That’s about 2.7 % of deaths worldwide. 35.3 million people around the world were infected with HIV by the end of 2012. About 5,700 more become infected every day. Rates vary dramatically by geographical location. HIV started in sub-Saharan Africa where almost one in 20 adults is suffering from AIDS. The region is home to 70 % of all people who have HIV. It is also home to 91 % of the HIV-positive children all over the world.

Prenatal Deaths of Newborns

It is the most common cause of perinatal mortality leading to almost 30 % of neonatal deaths. Infant respiratory distress syndrome is the leading cause of death in 1% of preterm infants. Birth defects cause about 21 % of neonatal death. According to WHO, as many as 1.1 million deaths were due to prematurity and low birth weight complications [81-100]. Three quarters of deaths happen within the first week of life. Lack of skilled medical care makes huge problem in developing countries. Many deaths can be avoided with good prenatal and postnatal care.

Conclusion

In spite of scientists and doctors having tremendous progress in disease diagnoses by using different sources like Echocardiography, Electrocardiogram, Coronary angiography, etc and have discovered many treatment methods still many of the disease need full cure. All of the above diagnosis methods are successfully used till now but some advanced techniques must come in future to cure the other deadliest diseases. Investigations should be limited to simple laboratory testing unless the clinical picture suggests some other diagnosis. Effective disease management, inventing new diagnostic methods and usage of certain drugs will bring a change in disease diagnosis in the coming future.

References

1. Sukemori S, et al. Dietary Supplementation with L-Carnitine Induces Equal Utilization of Long-Chain Fatty Acids for Energy Production in Rats Trained with Walking. J Vet Sci Med Diagn. 2016;5:4.
2. Boeria EJ, et al. Usefulness of Urine as a Sample for Detection of Brucella Spp in Male Canines. J Vet Sci Med Diagn. 2016;5:4.
3. Kalashnikova VA. The Use of Genodiagnostics for Typing of Helicobacter pylori in Monkeys. J Vet Sci Med Diagn. 2015;4:1.
4. Oryan A, et al. Nephrolithiasis among Slaughtered Cow in Iran: Pathology Findings and Mineral Compositions. J Vet Sci Med Diagn. 2015;4:1.
5. Nalubamba KS. Unusual Presentation of Extra-Genital Canine Transmissible Venereal Tumor in an Adult Cross-Breed Dog – Palatine and Rectal Lesions without Primary Genital Lesions. J Vet Sci Med Diagn. 2015;4:1.
6. Christina R, et al. Magnesium-Based Intramedullary Nailing System in a Sheep Model: Biomechanic Evaluation and First In Vivo Results. J Vet Sci Med Diagn. 2014;4:1.
7. Bagath M, et al. Protection against P. multocida B:2 using Recombinant 87kDa OMP Periplasmic Protein. J Vet Sci Med Diagn. 2015;4:1.
8. Barclay R and Yinduo Ji. Staphylococcal Toxins and Bovine Mastitis. J Vet Sci Med Diagn. 2015;4:1.
9. Hillman D. Effects of Extraneous Electricity on Dairy Cattle, Other Animals, and Humans - A Guide for Dairymen, Veterinarians, and Investigators of Stray Voltage. J Vet Sci Med Diagn. 2014;3:4.
10. El-Ashker M, et al. Gentamicin-induced Acute Kidney Injury in Equines is associated with Marked Acute Phase Response: An Experimental Study on Donkey (Equus asinus). J Vet Sci Med Diagn. 2014;4:2.
11. Thomas M, et al. Heat Tolerance in Attappaddy Black does Reared under Hot Humid Tropical Environment. J Vet Sci Med Diagn. 2015;4:2.
12. Recavarren M, et al. Leptospira Diagnosis in Serum and Urine of Dogs by Real Time PCR. J Vet Sci Med Diagn. 2015;4:2.
13. Lamparello NA, et al. Appendiceal Adenoma on F-18 FDG PET-CT in a Patient with Hodgkin Lymphoma: A Case Report and Literature Review. J Mol Biomark Diagn. 2016;7:294.
14. He Z. Diagnosis and Treatment of Diabetic Nephropathy in Type 1 and Type 2 Diabetes Patients. J Mol Biomark Diagn. 2016;7:295.
15. Tiwari S and Solanki PR. Emerging Aid in Oral Cancer Diagnosis. J Mol Biomark Diagn. 2015;6:e122.
16. Fatani SH, et al.  Correlation between Serum Anti-Apoptotic Bcl-2 Level and its Immunohistochemical Expression in Relation to Apoptosis in Gastric Cancer. J Mol Biomark Diagn. 2015;6:248.
17. Doustjalali SR, et al. Protein Map Standardization of Human Saliva Using Two Dimensional Gel Electrophoresis (2-DE). J Mol Biomark Diagn. 2015;6:249.
18. Zhao X, et al. Selection of Sensitive Methylation Markers for the Detection of Non-small Cell Lung Cancer. J Mol Biomark Diagn. 2015;6:250.
19. Villard A, et al. Diagnostic Value of Cell-free Circulating Micrornas for Obesity and Type 2 Diabetes: A Meta-Analysis. J Mol Biomark Diagn. 2015;6:251.
20. Blanco R, et al. Immunoreaction of 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside Correlates with High Histological Grade in some Tumors of Neuroectodermal and Epithelial Lineage. J Mol Biomark Diagn. 2015;6:252.
21. Schmidt K and Podmore I. Solid Phase Microextraction (Spme) Method Development in Analysis of Volatile Organic Compounds (Vocs) as Potential Biomarkers of Cancer. J Mol Biomark Diagn. 2015;6:253.
22. Saraswathy GR, et al. Blonanserin Induced Hypokinesia and Tardive Dyskinesia. J Mol Biomark Diagn. 2015;6:254.
23. Elia P, et al. Biomarkers for the Detection of Pre-Cancerous Stage of Cervical Dysplasia. J Mol Biomark Diagn. 2015;6:255.
24. Loh SH, et al. Systemic Clearance of Radiation-Induced Apoptotic Cells by SIGN-R1 and Complement Factors and their Involvement in Autoimmune Diseases. J Mol Biomark Diagn. 2015;6:256.
25. Meher S, et al. Pathophysiology of Oxidative Stress and Antioxidant Therapy in Acute Pancreatitis. J Mol Biomark Diagn. 2015;6:257.
26. Jiang C. Avandia: Cardiovascular Safety Concern Remains. J Mol Biomark Diagn. 2015;6:258.
27. Grynkiewicz G and Szeja W.  New Perspectives in Exploiting Secondary Metabolite Glycosides as Drug Leads. J Mol Biomark Diagn. 2015;6:259.
28. Saawarn S, et al. Cyclin D1: An Insight into its Physio-Pathological Role in Oral Squamous Cell Carcinoma. J Mol Biomark Diagn. 2015;6:260.
29. Das U, et al. Breast Cancer in Women of Younger than 35 Years: A Single Center Study. J Mol Biomark Diagn. 2015;6:261.
30. Esgalhado M and Mafra D (2015) Influence of Physical Exercise on Oxidative Stress and Inflammation in Hemodialysis Patients. J Mol Biomark Diagn 6:e120.
31. Yan L, et al. Pharmacokinetic Study of Cycloserine in Rat Lung and Blood Tissues. J Mol Biomark Diagn. 2015;6:230.
32. Chowdhury P, et al. Correlation of Serum Ferritin with Hepatic Iron Overload among Non-transfusion Dependent Beta Thalassaemia with Haemoglobin E Disease Patients from Eastern India. J Mol Biomark Diagn. 2015;6:231.
33. Khan F. Molecular Markers: An Excellent Tool for Genetic Analysis. J Mol Biomark Diagn. 2015;6:233.
34. Lisowska-Myjak B and Zytynska-Daniluk J. Changes in Physiology and Pathophysiology of Calprotectin Excretion from Neonate to Adult. J Mol Biomark Diagn. 2015;6:234.
35. Alkhiary W, et al. Serum Concentrations of Interleukin-33 and its Soluble Receptor sST2 in Patients with Persistent Atrial Fibrillation. J Mol Biomark Diagn. 2015;6:235.
36. Yadav AS and Jaggi S. Buccal Micronucleus Cytome Assay- A Biomarker of Genotoxicity. J Mol Biomark Diagn. 2015;6:236.
37. Kihara JH. Female Genital Schistosomiasis: A Neglected Tropical Disease Infecting Women of Reproductive Age in Endemic Areas. J Infect Dis Diagn. 2015;1:e101.
38. Iannuccelli V and Maretti E. Inhaled Micro- or Nanoparticles: Which are the Best for Intramacrophagic Antiinfectious Therapies?. J Infect Dis Diagn. 2015;1:e102.
39. Masgala A, et al. Multi Drug Resistant Gram Negative Pathogens in Long Term Care Facilities: A Steadily Arising Problem. J Infect Dis Diagn. 2015;1:101.
40. Wambani RJ, et al. Hepatitis B and C Co-Infections among HIV-1 Infected Patients Attending the Academic Model Providing Access to Healthcare Clinic, Kenya, 2014. J Infect Dis Diagn. 2015;1:102.
41. Wambani RJ, et al. Ebola Virus Disease: A Biological and Epidemiological Perspective of a Virulent Virus. J Infect Dis Diagn. 2016;1:103.
42. Santos ALS, et al. Candida Albicans Involvement in Denture-Related Stomatitis: A Serious and Real Clinical Concern. J Infect Dis Diagn. 2016;1:104.
43. Roever L and Borges ASR. Cardiac Steatosis: Is it Related to Ectopic Obesity, Insulin Sensitivity, Diabetes Mellitus and Metabolic Syndrome? J Cardiovasc Dis Diagn. 2015;3:e110.
44. Puente-Barragán AC, et al. Gated-SPECT Functional Assessment in Overweight and Obese Patients. J Cardiovasc Dis Diagn. 2015;3:226.
45. Shah M, et al. Coronary-Cameral Fistula and Coronary Ectasia as a Prelude to Ischemia in the Absence of Obstructive Disease-A Case Report. J Cardiovasc Dis Diagn. 2015;3:227.
46. Ramanathan AK and Papas G. Primary Use of Negative Pressure Dressings in Lower Extremity Distal Bypass Wounds. J Cardiovasc Dis Diagn. 2015;3:228.
47. Mohanty A. Usefulness of 3D Transthoracic Echocardiography in the Diagnosis of Congenital Left Ventricular Aneurysm. J Cardiovasc Dis Diagn. 2015;3:229.
48. Henriksson C, et al. Quality of Life in Patients Under Investigation for Unclear Chest Pain; Before and After Coronary Angiography. J Cardiovasc Dis Diagn. 2015;3:230.
49. Tilman V. Pulmonary Edema: A Unifying Pathophysiological Formula. J Cardiovasc Dis Diagn. 2015;3:194.
50. Oddershede L, et al. Long-term Cost-effectiveness of Endoscopic vs Open Vein Harvest for Coronary Artery Bypass Grafting. J Cardiovasc Dis Diagn. 2015;3:195.
51. Ivanova O and Ivanova M. Adaptation to Stresses Induced by the Effects of External Low Dose Ionizing Radiation. J Cardiovasc Dis Diagn. 2015;3:196.
52. Zafar R. An Insight into Pathogenesis of Cardiovascular Diseases. J Cardiovasc Dis Diagn. 2015;3:197.
53. Kalinauskiene E, et al. A Transfer for PCI versus Conservative Treatment at a Late Electrocardiographic Stage of Myocardial Infarction on Admission: Long-Term Outcomes. J Cardiovasc Dis Diagn. 2015;3:198.
54. Filho MFS, et al. Intraoperative Transesophageal Echocardiography to Evaluate Pediatric Patients Undergoing Atrial Septal Defect Procedure. J Cardiovasc Dis Diagn. 2015;3:199.
55. Wang L, et al. Catheter Ablation of Sinus Node Reentrant Tachycardia with a Non-Contact Mapping System. J Cardiovasc Dis Diagn. 2015;3:200.
56. Yahiro E, et al. Comparison of 64Cu and 68Ga for Molecular Imaging of Atherosclerosis using the Apolipoprotein A-I Mimetic Peptide FAMP. J Cardiovasc Dis Diagn. 2015;3:201.
57. Majumdar G, et al. Successful Surgical Management of Radial Artery Pseudo Aneurysm Following Trans-radial Coronary Artery Intervention: Report of Two Cases. J Cardiovasc Dis Diagn. 2016;S1:001.
58. Kar SK, et al. Post Balloon Stent Right Coronary Artery Aneurysm: Cardiologist’s Nightmare. J Cardiovasc Dis Diagn. 2016;S1:002.
59. Alajaji W, et al. Myocardial Contrast Echocardiography has Favorable Sensitivity and Specificity for Coronary Artery Disease Diagnosis in Patients with LBBB: A Meta-analysis. J Cardiovasc Dis Diagn. 2016;S1:003.
60. Ferroni F, et al. Calcified Pericarditis associated with Ventricular Septal Defect: Should We Close the Hole or Open Our Eyes? J Cardiovasc Dis Diagn. 2016;S1:004.
61. Li Q, et al. Risk of Intradialytic Hypotension in Hemodialysis Patients with Different Residual Urine Volume. J Cardiovasc Dis Diagn. 2016;S1:005.
62. Sanchez JM, et al. Fever Exacerbating Ventricular Fibrillation in Early Repolarization Syndrome. J Cardiovasc Dis Diagn. 2016;S1:006.
63. Fink N, et al. A Double Edged Sword-anticoagulation Treatment in a Patient with Mechanical Prosthetic Mitral Valve Complicated by Brain Hemorrhage. J Cardiovasc Dis Diagn. 2016;S1:007.
64. Altura BM, et al. Genotoxic Effects of Magnesium Deficiency in the Cardiovascular System and their Relationships to Cardiovascular Diseases and Atherogenesis. J Cardiovasc Dis Diagn. 2016;S1:008.
65. López MB, et al. Clinical Case: Dexmedetomidine for Non-invasive Mechanical Ventilation in Postoperative Cardiac Surgery. J Cardiovasc Dis Diagn. 2016;S1:009.
66. Mohammed A, et al. Electrical Cardioversion of Atrial Flutter in Dialysis Patient. J Cardiovasc Dis Diagn. 2014;2:159.
67. Mohapatra S, et al. Coronary Pulmonary Fistula: A Rare Case Presenting with Recurrent Chest Pain. J Cardiovasc Dis Diagn. 2014;2:160.
68. Stoll DP, et al. The Importance of Psychological Assessment and Support in Patients Suffering from Cardiovascular Disease or Undergoing Cardiac Treatment. J Cardiovasc Dis Diagn. 2014;2:161.
69. Naydenov SN, et al. Lipid- Lowering Potency and Tolerability of Generic Rosuvastatin in Bulgarian Patients with High and Very High Risk. J Cardiovasc Dis Diagn. 2014;2:162.
70. Ritu M and Manika M. Blood Homocystiene and Lipoprotein (A) Levels, Stress and Faulty Diet as Major Risk Factors for Early Cardiovascular Diseases in Indians. J Cardiovasc Dis Diagn. 2014;2:163.
71. Manov EI, et al. Early Left Ventricular Function Abnormalities in Obstructive Sleep Apnea. J Cardiovasc Dis Diagn. 2014;2:164.
72. Shivendra S, et al. Echocardiographic Changes in Patients with ESRD on Maintenance Hemodialysis-A Single Centre Study. J Cardiovasc Dis Diagn. 2014;2:165.
73. Kehinde AO and Adetoye AE. Diagnosis of Pulmonary Tuberculosis Using Genotype MTBDRplus Assay in Three Local Government Primary Health Centres of Osun State, Nigeria- a Pilot Study. J Med Microb Diagn. 2012;S3:001.
74. Therese SS, et al. The Spreading of Flaviviruses over the Continental Divide: a Challenge for Serologic Diagnostics. J Med Microb Diagn. 2013;S3:002.
75. Ejegod DM, et al. Clinical Validation of the BD Onclarity HPV Assay Using a Non- Inferiority Test. J Med Microb Diagn. 2013;S3:003.
76. Sanou I, et al. Hospital-based Sentinel Surveillance of Haemophilus influenzae Type b among Children in Burkina Faso, 2004-2012: Impact of Vaccine Introduction. J Med Microb Diagn. 2014;S3:004.
77. Amenu D. Probiotic Properties of Lactic Acid Bacteria from Human Milk. J Med Microb Diagn. 2015;S3:005.
78. Ehsani S, et al. The Role of Novel Molecular Techniques for Tuberculosis Diagnostics in the WHO European Region. J Med Microb Diagn. 2015;S3:006.
79. AL-Saffar AK and Al-Dahmoshi HOM. Effect of Argan Oil-Hydrogen Peroxide Mixture on Mycobacterium tuberculosis-In Vitro. J Med Microb Diagn. 2015;S3:008.
80. Mariani P, et al. Economic Impact of Microarray- Based Rapid Detection of Gram-Positive Organisms in Blood Cultures. J Med Microb Diagn. 2015;S3:009.
81. Regasa B. Drug Resistance Patterns of Bacterial Pathogens from Adult Patients with Pneumonia in Arba Minch Hospital, South Ethiopia. J Med Microb Diagn. 2014;3:151.
82. Oninla OA, et al. Superficial Fungi Skin Infections: The Bane of Dermatoses in Nigeria. J Med Microb Diagn. 2014;3:152.
83. Therese KL. A Pilot Study on the Detection of Multidrug Resistant Tuberculosis in Hospital Based Population of Chennai, India.J Med Microb Diagn. 2014;3:153.
84. Isaiah IN. Immunoinflammation and Elevated Serum Procalcitonin In Patients with Resistant Strain Mycobacterium Tuberculosis in Benin Metropolis. J Med Microb Diagn. 2014;3:154.
85. Isaiah IN and Ibhoje UU. Aflatoxin, G1, G2 and M1 Prenatal Exposure and its Sero-Dynamics amongst Pregnant Mothers in Adamawa State, North East of Nigeria. J Med Microb Diagn. 2014;3:155.
86. Chokkakula S, et al. Variable Number Tandem Repeats for Global Strain Typing and Strain Differentiation of Mycobacterium leprae. J Med Microb Diagn. 2014;3:156.
87. García B, et al. The Role of Heparan Sulfate Proteoglycans in Bacterial Infections. J Med Microb Diagn. 2014;3:157.
88. Rosa LP and da Silva FC. Antimicrobial Photodynamic Therapy: A New Therapeutic Option to Combat Infections. J Med Microb Diagn. 2014;3:158.
89. Tang F and Saier Jr. Transport Systems Conferring Pathogenicity to Escherichia coli. J Med Microb Diagn. 2014;3:159.
90. Mustafa HIS. Staphylococcus Aureus can Produce Catalase Enzyme when React with Human Wbcs as a Source of H2O2 Productions in Human Plasma or Serum in the Laboratory. J Med Microb Diagn. 2014;3:160.
91. Sultanik P and Pol S. Hepatitis Delta Virus: Epidemiology, Natural Course and Treatment. J Infect Dis Ther. 2016;4:271.
92. Krishna Prasanth B, et al. Distribution of Oral Manifestation among HIV Patients Attending Art Centers in Chennai. J Infect Dis Ther. 2016;4:272.
93. Dwibedi B. Herpes Simplex Encephalitis in Childhood. J Infect Dis Ther. 2016;4:273.
94. Karaca S and Inci R. Psoriasis: as an Imitation of Skin, Scalp and Nail Infections. J Infect Dis Ther. 2016;4:274.
95. Salwa MEK, et al. Heavy Metals Contaminants in Water and Fish from Four Different Sources in Sudan. J Infect Dis Ther. 2016;4:275.
96. Fikadu D, et al. Assessment of Utilization of Provider Initiated HIV Testing and Counseling and Associated Factors among Adult Out Patient Department Patients in Wonchi Woreda, South West Shoa Zone, Central Ethiopia. J Infect Dis Ther. 2016;4:276.
97. Tewari VV. Current Evidence on Prevention and Management of Early Onset Neonatal Sepsis. J Infect Dis Ther. 2016;4:277.
98. Gulich GA. Epidemiology, Driving Factors, Transmission and Control Options of Zika Virus: A Review. J Infect Dis Ther. 2016;4:278.
99. Baez CF, et al. First Report of Three Major Oncogenic Viruses: Human Papillomavirus, Epstein-Barr Virus And Merkel Cell Polyomavirus in Penile Cancer. J Infect Dis Ther. 2015;4:233.
100. Becka CM and Chacón-Cruz E. Meningococcal Disease. J Infect Dis Ther. 2015;3:235.